Pathophysiology of α- and β-thalassemia: Therapeutic implications

Seminars in Hematology

Volumn 38, Issue 4, 2001, Pages 343-349

  Rund, Deborah ^a   Rachmilewitz, Eliezer ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA GLOBIN; ALPHA TOCOPHEROL; ANKYRIN; ANTICOAGULANT AGENT; ANTIOXIDANT; ANTITHROMBIN III; ANTITHROMBOCYTIC AGENT; BETA GLOBIN; DEFERIPRONE; FLAVONOID; GAMMA GLOBIN; HEMOGLOBIN; HEMOGLOBIN A; HEMOGLOBIN H; INTERCELLULAR ADHESION MOLECULE 1; IRON; MEMBRANE LIPID; MEMBRANE PROTEIN; POLYPHENOL; PROTEIN C; PROTEIN S; RUTOSIDE; SPECTRIN; VASCULAR CELL ADHESION MOLECULE 1;

ALPHA THALASSEMIA; ANTIOXIDANT ACTIVITY; APOPTOSIS; BETA THALASSEMIA; ERYTHROCYTE MEMBRANE; ERYTHROID PRECURSOR CELL; HUMAN; HYPERCOAGULABILITY; LIPID PEROXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DENATURATION; REVIEW; THROMBOEMBOLISM;

EID: 0034778165     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(01)90028-9     Document Type: Article

References (43)

1. Phosphatidylserine in the outer leaflet of red blood cells from β-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes
2. In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites
3. Platelet survival in patients with beta-thalassemia
4. A chronic hypercoagulable state in β-thalassemia major exists already in childhood and may be induced by the abnormal erythrocytes
5. Ferrokinetics in man
6. Nonspecific serum iron in thalassemia: Quantitation and chemical reactivity
7. Primaquine-induced superoxide production by β-thalassemic red blood cells
8. Protective effects of tea polyphenols against oxidative damage to red blood cells
9. Studies on curcumin and curcuminoids: XXVI. Antioxidant effects of curcumin on the red blood cell membrane
10. Hydroxyl radical generation in β-thalassemia red blood cells
11. Protective effects of rutin against hemoglobin oxidation
12. Auto-oxidation and a membrane associated "Fenton reagent": A possible explanation for development of membrane lesions in sickle erythrocytes
13. Comparison of the proco-agulant activity of red blood cells from patients with homozygous sickle cell disease and β-thalassemia
14. Non-specific serum iron in thalassemia: An abnormal serum iron fraction of potential toxicity
15. Alpha thalassemia
16. Enhanced adherence of β-thalassaemic erythrocytes to endothelial cells
17. The beta and delta-thalassemia repository
18. Ferritin concentration in normal and abnormal erythrocytes measured by immunoradiometric assay with antibodies to heart and spleen ferritin and Mossbauer spectroscopy
19. Defective spectrin dimer self-association in thalassemic red cells
20. Ineffective erythropoiesis in beta-thalassemia major is due to apoptosis at the polychromatophilic normoblast stage
21. Ultrastructural studies in beta thalassaemia major
22. Ultra-structure of the inclusion bodies and nuclear abnormalities in β-thalassemic erythroblasts
23. A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in Thai patients with thalassemia
24. Free radicals in biology: The involvement of radical reactions in aging and carcinogens
25. Formation of hemichromes from oxidized hemoglobin subunits. Second International Symposium on Cooley's Anemia
26. Denaturation of the normal and abnormal hemoglobin molecule
27. Studies on the stability of oxyhemoglobin A and its constituent chains and their derivatives
28. Role of haemichromes in the formation of inclusion bodies in haemoglobin H disease
29. Vitamin E deficiency in β-thalassemia major: Changes in hematological and biochemical parameters after a therapeutic trial with α-tocopherol 1- 3
30. In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with β-thalassemia major
31. Globin chain specificity of oxidation-induced changes in red blood cell membrane properties
32. Cellular and membrane properties of alpha and beta thalassemic erythrocytes are different: Implication for differences in clinical manifestations
33. Entrapment of purified alpha hemoglobin chains in normal erythrocytes: A model for beta thalassemia
34. Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo
35. Haemoglobinopathies and red cell membrane function
36. Differing erythrocyte membrane skeletal protein defects in alpha and beta thalassemia
37. Erythrocyte-endothelial cell adherence in sickle cell disorders
38. Tissue factor expression by endothelial cells in sickle cell anemia
39. Circulating activated endothelial cells in sickle cell anemia
40. Molecular basis for dominantly inherited inclusion body beta-thalassemia
41. The correlation between red cell survival and excess of alpha-globin synthesis in betathalassemia
42. Hemichrome binding to band 3: Nucleation of Heinz bodies on the erythrocyte membrane
43. Accelerated programmed cell death (apoptosis) in erythroid precursors of patients with severe beta-thalassemia (Cooley's anemia)